Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
208.2 SEK | +0.10% | +81.83% | +63.81% |
01:40pm | Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39 | MT |
10:28am | Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.81% | 1.05B | |
+15.54% | 77.63B | |
+12.05% | 8.78B | |
+58.17% | 4.93B | |
-14.94% | 4.79B | |
0.00% | 3.8B | |
+21.94% | 2.46B | |
-26.63% | 2.2B | |
+16.75% | 2.1B | |
-37.97% | 1.96B |
- Stock Market
- Equities
- CALTX Stock
- News Calliditas Therapeutics AB
- Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise